Medicus PharmaMDCX
13F holders, Q1 2025 (March 31)7holders +4
4new positions
1sold out
$3.72avg. 13F price*
At the end of Q1 2025, 7 institutions reported holding Medicus Pharma Ltd. (MDCX) in their 13F filings, up 4 from Q4 2024. 4 opened new positions and 1 sold out. The largest holders were Interchange Capital Partners, LLC ($6.2M), Armistice Capital, LLC ($4.7M) and Private Advisor Group, LLC ($211K).
- Company
- Medicus Pharma Ltd.
- CUSIP
- 58471K202
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $5.0M |
| Exits | 1 | $42K |
All 13F filers, Q4 2024 → Q1 2025: 1,553,818 shares bought and 17,100 shares sold, net +1,536,718 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| Interchange Capital Partners, LLC | 1.73% | Add +14.1% | 1,661,871 | $6.2M |
| Armistice Capital, LLC | 0.13% | New | 1,266,000 | $4.7M |
| Private Advisor Group, LLC | 0.00% | New | 56,750 | $211K |
| Patriot Investment Management Group, Inc. | 0.01% | Add +0.3% | 29,203 | $109K |
| UBS Group AG | 0.00% | New | 21,262 | $79K |
| Base Wealth Management LLC | 0.03% | — | 11,543 | $43K |
| Osaic Holdings, Inc. | 0.00% | New | 5,000 | $19K |
"% of holder's portfolio" is MDCX's weight in each manager's 13F, not the share of Medicus Pharma Ltd. the manager owns.